Manassas Clinical Research Center
Manassas, Virginia, United States
Research institute in Manassas, Virginia
9001 Digges Rd, Manassas, VA 20110
About Manassas Clinical Research Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Gilead Sciences
5
Allergan
4
Eli Lilly and Company
4
Ionis Pharmaceuticals, Inc.
4
Boehringer Ingelheim
3
Kowa Research Institute, Inc.
3
AstraZeneca
2
Bristol-Myers Squibb
2
Evoke Pharma
2
Helixmith Co., Ltd.
2
Clinical Trials at Manassas Clinical Research Center
During the past decade, Manassas Clinical Research Center conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 29 clinical trials were completed, i.e. on
average, 70.7% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 21 clinical trials were completed. i.e. 91.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
2006-06-01
2009-01-01
Completed
352
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
2006-09-01
2010-04-01
Terminated
282
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
2009-06-01
2012-06-01
Completed
841
Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension
2009-06-01
Completed
412
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker
2010-07-01
2013-02-01
Completed
2,996
A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication
2010-10-01
2013-02-01
Completed
2,245
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Manassas Clinical Research Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Gilead Sciences" with 5 trials
sponsored, "Allergan" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Ionis Pharmaceuticals, Inc."
with 4 trials sponsored. Other sponsors include 35 different institutions and
companies that sponsored additional 34 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Manassas Clinical Research Center"
#1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Cyclerion Therapeutics" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Manassas Clinical Research Center
According to Clinical.Site data, the most researched conditions in "Manassas Clinical Research Center" are
"Hypertension" (6 trials), "Diabetes Mellitus, Type 2" (5 trials), "Severe Hypertriglyceridemia" (5 trials), "Diabetes Mellitus" (4 trials) and "Gastroparesis" (4 trials). Many other conditions were trialed in "Manassas Clinical Research Center" in a lesser frequency.
Clinical Trials Intervention Types at Manassas Clinical Research Center
Most popular intervention types in "Manassas Clinical Research Center" are "Drug" (56 trials), "Other" (7 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (32 trials), "Relamorelin" (3 trials), "Dapagliflozin" (2 trials), "Darusentan" (2 trials) and "Diet" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Manassas Clinical Research Center
The vast majority of trials in "Manassas Clinical Research Center" are
59 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Manassas Clinical Research Center
Currently, there are NaN active trials in "Manassas Clinical Research Center".
undefined are not yet recruiting,
7 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 38 completed trials in Manassas Clinical Research Center,
1 suspended trials,
and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Manassas Clinical Research Center, 0 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 32 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 6 trials, and there were
also 1 trials that are defined as “Not Applicable".